Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine
- PMID: 18252000
- PMCID: PMC2266770
- DOI: 10.1186/1475-2875-7-29
Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine
Abstract
Background: Kenya recently changed its antimalarial drug policy to a specific artemisinin-based combination therapy (ACT), artemether-lumefantrine (AL). New national guidelines on the diagnosis, treatment and prevention were developed and disseminated to health workers together with in-service training.
Methods: Between January and March 2007, 36 in-depth interviews were conducted in five rural districts with health workers who attended in-service training and were non-adherent to the new guidelines. A further 20 interviews were undertaken with training facilitators and members of District Health Management Teams (DHMTs) to explore reasons underlying health workers' non-adherence.
Results: Health workers generally perceived AL as being tolerable and efficacious as compared to amodiaquine and sulphadoxine-pyremethamine. However, a number of key reasons for non-adherence were identified. Insufficient supply of AL was a major issue and hence fears of stock outs and concern about AL costs was an impediment to AL prescription. Training messages that contradicted the recommended guidelines also led to health worker non-adherence, compounded by a lack of follow-up supervision. In addition, the availability of non-recommended antimalarials such as amodiaquine caused prescription confusion. Some health workers and DHMT members maintained that shortage of staff had resulted in increased patient caseload affecting the delivery of the desirable quality of care and adherence to guidelines.
Conclusion: The introduction of free efficacious ACTs in the public health sector in Kenya and other countries has major potential public health benefits for Africa. These may not be realized if provider prescription practices do not conform to the recommended treatment guidelines. It is essential that high quality training, drug supply and supervision work synergistically to ensure appropriate case management.
Similar articles
-
Provider knowledge of treatment policy and dosing regimen with artemether-lumefantrine and quinine in malaria-endemic areas of western Kenya.Malar J. 2012 Dec 29;11:436. doi: 10.1186/1475-2875-11-436. Malar J. 2012. PMID: 23273046 Free PMC article.
-
Translation of artemether-lumefantrine treatment policy into paediatric clinical practice: an early experience from Kenya.Trop Med Int Health. 2008 Jan;13(1):99-107. doi: 10.1111/j.1365-3156.2007.01980.x. Trop Med Int Health. 2008. PMID: 18291008 Free PMC article.
-
Adherence to prescribed artemisinin-based combination therapy in Garissa and Bunyala districts, Kenya.Malar J. 2011 Sep 23;10:281. doi: 10.1186/1475-2875-10-281. Malar J. 2011. PMID: 21943224 Free PMC article.
-
Dispersible formulation of artemether/lumefantrine: specifically developed for infants and young children.Malar J. 2009 Oct 12;8 Suppl 1(Suppl 1):S7. doi: 10.1186/1475-2875-8-S1-S7. Malar J. 2009. PMID: 19818174 Free PMC article. Review.
-
Factors influencing health workers' adherence to malaria treatment guidelines in under-five children in Nigeria: A scoping review.Malariaworld J. 2024 Oct 15;15:11. doi: 10.5281/zenodo.13934643. eCollection 2024. Malariaworld J. 2024. PMID: 39502332 Free PMC article.
Cited by
-
Tracking the quality of care for sick children using lot quality assurance sampling: targeting improvements of health services in Jigawa, Nigeria.PLoS One. 2012;7(9):e44319. doi: 10.1371/journal.pone.0044319. Epub 2012 Sep 27. PLoS One. 2012. PMID: 23028519 Free PMC article.
-
The quest for universal access to effective malaria treatment: how can the AMFm contribute?Malar J. 2010 Oct 8;9:274. doi: 10.1186/1475-2875-9-274. Malar J. 2010. PMID: 20932286 Free PMC article.
-
Diagnosis of malaria: challenges for clinicians in endemic and non-endemic regions.Mol Diagn Ther. 2008;12(5):299-306. doi: 10.1007/BF03256295. Mol Diagn Ther. 2008. PMID: 18803428 Review.
-
A retrospective evaluation of the quality of malaria case management at twelve health facilities in four districts in Zambia.Asian Pac J Trop Biomed. 2014 Jun;4(6):498-504. doi: 10.12980/APJTB.4.2014C153. Asian Pac J Trop Biomed. 2014. PMID: 25182953 Free PMC article.
-
Interrupting transmission of soil-transmitted helminths: a study protocol for cluster randomised trials evaluating alternative treatment strategies and delivery systems in Kenya.BMJ Open. 2015 Oct 19;5(10):e008950. doi: 10.1136/bmjopen-2015-008950. BMJ Open. 2015. PMID: 26482774 Free PMC article. Clinical Trial.
References
-
- World Health Organization . Antimalarial drug combination therapy-Report of a technical consultation. Geneva: World Health Organization; 2001.
-
- World Health Organization Access to antimalarial medicines: improving the affordability and financing of artemisinin based combination therapies. Geneva. 2003. pp. 1–15.
-
- Ministry of Health . Integrated Management of Childhood Illnesses. Ministry of Health, Republic of Kenya; 2000.
-
- Ministry of Health . National guidelines for diagnosis, treatment and prevention of malaria for health workers in Kenya. Ministry of Health, Republic of Kenya; 2006.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical